Scientists identify genetic signatures for aggressive form of prostate cancer
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...
Cancer
Oct 08, 2012 |
5 / 5 (1) |
0
|
Cancer researchers discover new type of retinoblastoma in babies
A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network (UHN), has discovered a new type of retinoblastoma, a rapidly developing eye ...
Cancer
Mar 12, 2013 |
5 / 5 (2) |
0
|
Researchers discover breakthrough in ovarian cancer
Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...
Cancer
Feb 14, 2013 |
5 / 5 (3) |
0
|
Study drug is first to help patients with recurrent low-grade ovarian cancer
Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.
Cancer
Feb 08, 2013 |
not rated yet |
0
|
Researchers report first success of targeted therapy in most common non-small cell lung cancer
A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone ...
Cancer
Nov 28, 2012 |
not rated yet |
0
|
Researchers report first effective treatment of tumors arising from common genetic disease NF1
Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.
Cancer
Nov 01, 2012 |
3 / 5 (1) |
0
|
Breast cancer and periods: Link more important in specific cancers
(Medical Xpress)—The younger a woman starts her periods, and the later she finishes, the more at risk she is from developing breast cancer. Now a new study led by Oxford researchers shows that these factors ...
Cancer
Oct 18, 2012 |
3 / 5 (1) |
0
|
New drug shrinks brain tumours in melanoma patients
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer
Oct 08, 2012 |
not rated yet |
0
|
Genetic markers hope for new brain tumor treatments
Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.
Cancer
Jun 15, 2012 |
5 / 5 (1) |
0
|
Blood test could lead to improved diagnosis and treatment of breast cancer
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.
Cancer
Jun 05, 2012 |
not rated yet |
0
Cancer incidence predicted to increase 75 percent by 2030
The global cancer burden is set to surge more than 75% by 2030, according to new research published Online First in the Lancet Oncology. The rise is predicted to be even larger in the developing world, with the poorest countr ...
Cancer
May 31, 2012 |
5 / 5 (2) |
0
|
Heart-damaging side effects of cancer drugs under-reported in studies
The under-reporting of the possible side effects of heart damage from cancer drugs puts patients at an increased risk for heart failure, according to two researchers at the Stanford University School of Medicine.
Cancer
Mar 26, 2012 |
4 / 5 (1) |
0
|
What causes cancer?
(Medical Xpress) -- Fears that involuntary exposure to chemicals in food and consumer products causes cancer are not supported by evidence, and anxiety about their dangers is diverting attention from proven methods of cancer ...
Cancer
Feb 28, 2012 |
5 / 5 (2) |
1
|
Studies help clarify the role of lapatinib and trastuzumab in treating HER2 positive breast cancer
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Cancer
Jan 16, 2012 |
5 / 5 (2) |
0
|
Birth control device cuts cancer risk: study
Intra-uterine devices designed to prevent conception may also protect against cervical cancer, according to a study covering more than 20,000 women that was released on Tuesday.
Cancer
Sep 13, 2011 |
not rated yet |
1
